KISS has appointed Kathryn Sparrow as Account Director as part of its ongoing growth plan to meet new business requirements across the tech and science sectors.
Kathryn brings with her 9 years of agency experience delivering strategic consultancy, project management and editorial expertise for global pharmaceutical and biotech clients.
With a degree in Molecular Genetics from the University of Sussex, and a background in medical communications, Kathryn is an expert in converting complex information into clear communications.
Kathryn has collaborated with clients such as AstraZeneca, GSK, Novo Nordisk and Roche to develop communications primarily within medical education during drug development stages, product launches and life-cycle management. Her experience includes strategic communications planning and delivery of materials across print and digital media, publications planning and management, and organising events.
KISS Managing Director Sarah Reakes said, “Kathryn’s extensive experience across the pharma and biotech industries is a strategic appointment to ensure we can build even further on our work with clients in these sectors.
Commenting on her appointment Kathryn said, “I’m thrilled to become part of the team – KISS has a great reputation, so I jumped at the chance to join such a dynamic agency and work with even more brands and organisations that are changing the world.”